SCHEMBL17134515

SCHEMBL17134515

Cc1ccccc1Nc1c(C(=O)O)cnc(Cl)c1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 2/20 0.51
▸ FTO Q9C0B1 2/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ AKR1B10 O60218 1/20 0.51
▸ ABCB11 O95342 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ CHRM1 P11229 1/20 0.51
▸ FABP2 P12104 1/20 0.51
▸ RXRA P19793 1/20 0.51
▸ TBXA2R P21731 1/20 0.51
▸ NR4A1 P22736 1/20 0.51
▸ PTGS1 P23219 1/20 0.51
▸ PDE4A P27815 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ PTGS2 P35354 1/20 0.51
▸ AKR1C3 P42330 1/20 0.51
▸ NR4A2 P43354 1/20 0.51
▸ AKR1C2 P52895 1/20 0.51
▸ AKR1C1 Q04828 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17134582 0.89 MEN1 (0.48) TTRFTOMEN1KMT2AAKR1B10
SCHEMBL17134774 0.84 RAPGEF4 (0.48) TTRFTOMEN1KMT2AAKR1B10
SCHEMBL17135099 0.84 TTR (0.48) TTRFTOMEN1KMT2AAKR1B10
SCHEMBL17134851 0.82 CLCN2 (0.55) FTOMEN1KMT2AMAPK1
SCHEMBL17688897 0.80 AKR1C3 (0.48) TTRFTOMEN1KMT2AAKR1B10
Hydrochloric Acid SCHEMBL8537632 0.77 CSF1R (0.54) CSF1R
SCHEMBL17134583 0.77 MAP2K1 (0.51) CSF1R
SCHEMBL17134561 0.76 EGFR (0.49) MEN1KMT2AAKR1C3AKR1C2CSF1R
SCHEMBL17134934 0.76 PTGS2 (0.50) PTGS2CSF1R
SCHEMBL11581567 0.76 MEN1 (0.59) TTRFTOMEN1KMT2AAKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2927214-B1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KIRIN CO LTD (JP) 2018-03-21 — — EP disclosed
US-9701689-B2 Substituted pyridines and pyridazines as CCR10 receptor inhibitors KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-07-11 — — US disclosed
US-20150299214-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KIRIN CO., LTD. (JP) 2015-10-22 — — US disclosed
EP-2927214-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND Kyowa Hakko Kirin Co., Ltd. (JP) 2015-10-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299214-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND ARG1, H1-0, TYR TTR 3743/4885FTO 3703/4885MEN1 1212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback